Nakshine VS, Jogdand SD. A comprehensive review of gestational diabetes mellitus: impacts on maternal health, fetal development, childhood outcomes, and long-term treatment strategies. Cureus. 2023;15(10):e47500.
PubMed PubMed Central Google Scholar
Yong HY, MohdShariff Z, MohdYusof BN, Rejali Z, Tee YYS, Bindels J, et al. Independent and combined effects of age, body mass index and gestational weight gain on the risk of gestational diabetes mellitus. Sci Rep. 2020;10(1):8486.
Article CAS PubMed PubMed Central Google Scholar
Trivett C, Lees ZJ, Freeman DJ. Adipose tissue function in healthy pregnancy, gestational diabetes mellitus and pre-eclampsia. Eur J Clin Nutri. 2021;75(12):1745–56.
Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C, et al. Chronic adipose tissue inflammation linking obesity to insulin resistance and type 2 diabetes. Front Physiol. 2020;29(10):1607.
Sheiner E. Gestational diabetes mellitus: long-term consequences for the mother and child grand challenge: how to move on towards secondary prevention? Front Clin Diab Healthcare. 2020;1:546256.
Reddi Rani P, Begum J. Screening and diagnosis of gestational diabetes mellitus, where do we stand. J Clin Diagn Res. 2016;10(4):QE01.
Bourebaba L, Marycz K. Pathophysiological implication of fetuin-A glycoprotein in the development of metabolic disorders: a concise review. J Clin Med. 2019;8(12):2033.
Article CAS PubMed PubMed Central Google Scholar
Chekol Abebe E, Tilahun Muche Z, Behaile T/Mariam A, Mengie Ayele T, Mekonnen Agidew M, Teshome Azezew M, et al. The structure, biosynthesis, and biological roles of fetuin-A: a review. Front Cell Dev Biol. 2022;10:945287.
Fu J, Retnakaran R. The life course perspective of gestational diabetes: an opportunity for the prevention of diabetes and heart disease in women. EClinicalMedicine. 2022;1:45.
Pan X, Wen SW, Bestman PL, Kaminga AC, Acheampong K, Liu A. Fetuin-A in metabolic syndrome: a systematic review and meta-analysis. PLoS ONE. 2020;15(3):e0229776.
Article CAS PubMed PubMed Central Google Scholar
Trepanowski JF, Mey J, Varady KA. Fetuin-A: a novel link between obesity and related complications. Int J Obes (Lond). 2015;39(5):734–41.
Article CAS PubMed Google Scholar
Farhan S, Handisurya A, Todoric J, Tura A, Pacini G, Wagner O, et al. Fetuin-A characteristics during and after pregnancy: result from a case control pilot study. Int J Endocrinol. 2012;2012.
Kansu-Celik H, Ozgu-Erdinc AS, Kisa B, Findik RB, Yilmaz C, Tasci Y. Prediction of gestational diabetes mellitus in the first trimester: comparison of maternal fetuin-A, N-terminal proatrial natriuretic peptide, high-sensitivity C-reactive protein, and fasting glucose levels. Arch Endocrinol Metab. 2019;63(2):121–7.
PubMed PubMed Central Google Scholar
Yakout SM, Hussein S, Al-Attas OS, Hussain SD, Saadawy M, Al-Daghri NM. Hepatokines fetuin A and fetuin B status in women with/without gestational diabetes mellitus [Internet]. Am J Transl Res. 2023;15.
Kralisch S, Hoffmann A, Lössner U, Kratzsch J, Blüher M, Stumvoll M, et al. Regulation of the novel adipokines/ hepatokines fetuin A and fetuin B in gestational diabetes mellitus. Metabolism. 2017;1(68):88–94.
Wang Y, Koh WP, Jensen MK, Yuan JM, Pan A. Plasma fetuin-A levels and risk of type 2 diabetes mellitus in a Chinese population: a nested case-control study. Diabetes Metab J. 2019;43(4):474–86.
Article PubMed PubMed Central Google Scholar
Šimják P, Cinkajzlová A, Anderlová K, Kloučková J, Kratochvílová H, Lacinová Z, et al. Changes in Plasma concentrations and mRNA expression of hepatokines fetuin A, fetuin B and FGF21 in physiological pregnancy and gestational diabetes mellitus. Physiol Res. 2018;67:S531–42.
Lu D, Yang M, Yao Y, Xie Y. A clinical research study on the respective relationships between visfatin and human fetuin A and pregnancy outcomes in gestational diabetes mellitus. Taiwan J Obstet Gynecol. 2019;58(6):808–13.
Zbucka-Kretowska M, Kuzmicki M, Telejko B, Goscik J, Ciborowski M, Lipinska D, et al. First-trimester irisin and fetuin-a concentration in predicting macrosomia. J Maternal-Fetal Neonatal Med. 2019;32(17):2868–73.
Al-Said NH, Taha FM, Abdel-Aziz GM, Abdel-Tawab MS. Fetuin-A level in type 2 diabetic patients: relation to microvascular complications. Egypt J Intern Med. 2018;30(3):121–30.
Karamfilova V, Nedeva I, Gatev T, Gateva A, Assyov Y, Gerganova A, et al. Relationship of serum fetuin-A with metabolic and vascular parameters in patients with prediabetes and type 2 diabetes mellitus. Pharmacia. 2023;70(4):1455–61.
Wang WJ, Zhang L, Zheng T, Zhang GH, Du K, Yang MN, et al. Fetuin-A and fetal growth in gestational diabetes mellitus. BMJ Open Diabetes Res Care. 2020;8(1).
Asghar A, Alam A, Fatima F. AHSG rs4918 Polymorphism poses a weak predisposition to insulin resistance during pregnancy. Pakistan J Med Assoc. 2018;68(5):698–701.
Rottenkolber M, Ferrari U, Holland L, Aertsen S, Kammer NN, Hetterich H, et al. The diabetes risk phenotype of young women with recent gestational diabetes. J Clin Endocrinol Metab. 2015;100(6):E910–8.
Article CAS PubMed Google Scholar
Iyidir OT, Degertekin CK, Yilmaz BA, Altinova AE, Toruner FB, Bozkurt N, et al. Serum levels of fetuin A are increased in women with gestational diabetes mellitus. Arch Gynecol Obstet. 2015;291(4):933–7.
Comments (0)